Protéus' affiliate company PCAS Biosolution operates four cGMP manufacturing sites regularly audited by the FDA. All of those sites were acquired from major pharmaceutical companies between 1998 and 2004 and have an outstanding track record of API production.
Each site has all project management resources required for the custom development and manufacturing of cGMP intermediates and APIs. Three ISO 9001 sites provide cost-effective back integration for non regulated compounds.
Protéus in house manufacturing team delivers suitable amounts of biocatalysts to feed the chemical plants. A dedicated team is in charge of :
-
Delivering comprehensive technical packages for the successful scaling up in chemical production facilities.
-
Adapting and optimizing processes.
-
Providing biocatalysts test batches for product/process validation and process books for cubic meter scale manufacturing.